ACIT, CENTRAL CIRCLE-1(2), HYDERABAD vs. AUROBINDO PHARMA LIMITED, HYDERABAD
No AI summary yet for this case.
Income Tax Appellate Tribunal, HYDERABAD BENCHES “B”, HYDERABAD
Before: SHRI K.NARASIMHA CHARY & SHRI MADHUSUDAN SAWDIA
आयकर अपीलीय अिधकरण, हैदराबाद पीठ म� IN THE INCOME TAX APPELLATE TRIBUNAL HYDERABAD BENCHES “B”, HYDERABAD BEFORE SHRI K.NARASIMHA CHARY, JUDICIAL MEMBER & SHRI MADHUSUDAN SAWDIA, ACCOUNTANT MEMBER आ.अपी.सं / ITA No. 320/Hyd/2023 (िनधा�रण वष� / Assessment Year: 2016-17) ACIT, Central Circle 1(2) Vs. Aurobindo Pharma Ltd Hyderabad Hyderabad [PAN : AABCA7366H] आ.अपी.सं / ITA No. 351/Hyd/2023 (िनधा�रण वष� / Assessment Year: 2016-17) Aurobindo Pharma Ltd Vs. ACIT, Central Circle 1(2) Hyderabad Hyderabad PAN: AABCA7366H अपीलाथ� / Appellant �� यथ� / Respondent राज� व �ारा/Revenue by: Shri M Vijay Kumar, CIT(DR) िनधा�रती �ारा/Assessee by: Advocate BG Reddy
सुनवाई की तारीख/Date of hearing: 18 /06/2024 घोषणा की तारीख/Pronouncement on: 23/07/2024 आदेश / ORDER PER K. NARASIMHA CHARY, J.M: Aggrieved by the order dated 29.03.2023 passed by the learned Commissioner of Income Tax (Appeals)- 11, Hyderabad (“Ld. CIT(A)”), in the case of Aurobindo Pharma Ltd (“the assessee”) for the assessment year 2016-17, both the Revenue and the assessee preferred these appeals. 2. Assessee is a company engaged in manufacture and sale of bulk drugs, Ac�ve Pharmaceu�cal Ingredients (APIs) and other pharmaceu�cal products. For the assessment year 2016-17, it filed the return of income on 28/11/2016. In respect of the interna�onal transac�ons of Corporate
Guarantee fee and interest on receivables, the learned Transfer Pricing Officer (learned TPO) suggested upward adjustments incorpora�ng which the learned Assessing Officer passed the dra� assessment order. Assessee reported no objec�on for passing the final order pursuant to which the final assessment order was passed, which was challenged before the learned CIT(A). Learned CIT(A), by way of impugned order disposed of the appeal giving part relief on all the three counts, in respect of which both the assessee and Revenue preferred these appeals. 3. Insofar as these two appeals are concerned, all these three issues are involved. Those are addi�ons made in respect of the Corporate Guarantee commission, interest on receivables and disallowance of weighted deduction claimed under section 35(2AB) of the Income Tax Act, 1961 (‘the Act’). We shall now proceed to answer these three issues in the light of the submissions made on either side and available material on record. 4. Coming to the issue relating to the corporate guarantee, contention of assessee before the learned TPO was that the corporate guarantees not an international transaction and it does not require any benchmarking at all on the ground that it is the responsibility of the parent company to provide guarantee to its subsidiary companies, and, therefore, it is to be categorised as shareholders activity. 5. Learned TPO discarded the plea of the assessee that the corporate guarantee is not an international transaction, and based on a number of decisions of the Tribunal enumerated at paragraph No. 10.4.2 (i) of his order and charged the same at 2% for the corporate guarantee of above Rs. 10 crores and suggested upward adjustment. Learned CIT(A) upheld the view taken by the learned TPO that such a transaction would be covered within the meaning of an international transaction. Learned CIT(A), however, quantified such guarantee at 0.53% instead of 2% by following the decision of a Co-ordinate Bench of the Tribunal in the case of Mylan Laboratories Ltd. vs. ACIT [2015] 63 taxmann.com 179 (Hyderabad - Trib.) and Rain Commodities Ltd., [2016] taxmann.com 240.
Page 2 of 14
Assessee, vide ground No. 1 and 2 of its appeal, contended that corporate guarantee was given by the assessee as a procedural compliance for availing of credit facilities by its subsidiaries and for the overall benefit of the group and it was provided as a part of the parental obligation to its subsidiaries and therefore, it is in the nature of shareholding service. By way of ground No. 3 assessee further contended that the corporate guarantee commission at the rate 0.53% as directed by the Ld. CIT(A) on the guarantees provided by the assessee is excessive and since the assessee had already offered commission at 0.50% on the guarantees given the same may be accepted. Finding of the learned CIT(A) is challenged by the Revenue on the ground that adoption of 0.53% as commission on corporate guarantee relying on the rates determined in assessment year 2007-08 in the case of Mylan Laboratories Ltd., (supra), is incorrect. 7. On this issue it is vehemently argued by the learned AR before us that the transac�on rela�ng the issue of corporate guarantee does not involve any costs to the assessee and does not fall within the scope of the term ‘interna�onal transac�on’ even a�er the inser�on of explana�on to sec�on 92B of the Act by Finance Act, 2012 with effect from 01/04/2002, and, therefore, there is no requirement of such transac�on to be reported in form No. 3CEB. Learned DR, however, submi�ed that this issue is no longer available to be agitated by the assessee and it is descended by the Hon’ble Madras High Court in the case of PCIT Vs. Redington (India) Ltd., (2020) 122 taxmann.com 136 (MAD). 8. Learned AR in the alterna�ve, pleaded that corporate guarantee at 0.53% determined by the learned CIT(A) is too high and cannot be sustained. Basing on the view taken by the Co-ordinate Benches of this Tribunal in the cases of Aster Private Limited Vs. DCIT in ITA No. 220/Hyd/2015 and DCIT Vs. Lanco Infratech Limited, 81 taxmann.com 381 (Hyderabad Tribunal) he prayed that the ALP in respect of Corporate Guarantee fee may be determined at 0.25%. He further submi�ed that the guarantee fees charged by SEBI from the assessee in respect of guarantee extended on its behalf was only 0.20%. On this aspect, the learned DR submi�ed that the ALP at 0.20% and also 0.53%, as determined by the
Page 3 of 14
learned CIT(A) is absurdly low. In the alterna�ve he submi�ed that following the view taken by the Hon’ble Bombay High Court in the case of Glenmark Pharmaceu�cals Ltd. Vs. Addl. CIT [2014] 43 taxmann.com 191 (Mumbai - Trib.) may be followed. 9. In view of the decision of the Hon’ble Madras High Court in the case of Redington (India) Ltd. (supra), we have no second thought, and this decision is applicable to the facts of the case. No further debate by the Tribunal is permissible, when the higher forum decided the issue. Corporate guarantee is an interna�onal transac�on, requiring benchmarking. 10. Though the learned DR argued that adoption of 0.53% as commission on corporate guarantee relying on the rates determined in assessment year 2007-08 in the case of Mylan Laboratories Ltd., (supra) is incorrect, no useful guidance is provided with reference to any latest decisions or other material, so as to take a different approach in respect of the quantification of the commission on corporate guarantee. 11. On the other hand, a Coordinate Bench of this Tribunal in assessee’s own case for the assessment year 2018-19 in ITA No. 485/Hyd/ 2022 considered this issue in extenso and held that ALP on account of corporate guarantee at the 0.50% on the amount guaranteed is proper commission. For the sake of completeness, relevant observations of the Coordinate Bench are extracted hereunder,- We have considered the submissions and found that the charges paid by the assessee cannot be compared for the purposes of determining the ALP of corporate guarantee commission. In our view, no third party would provide similar type of services/corporate guarantee on behalf of its AE and expose itself to the risk of giving the corporate guarantee. Therefore, the charges paid by the assessee to SBI cannot be compared for the purpose of determining the ALP of corporate guarantee commission. The Co-ordinate Bench in the case of Vivimed Labs vide its decision dated 12-04-2022 had adjudicated corporate guarantee commission @ 0.5% qua the extent of the amount of the assessee's corporate guarantee actually u�lised in these four assessment years. Therea�er, similar view had been taken by various Tribunals restric�ng the addi�on to 0.5% of the amount guaranteed as corporate guarantee commission. Recently, Delhi Tribunal in the case of Havells India Ltd. Vs. ACIT
Page 4 of 14
(LTU) in ITA No.6509/Del/2018 dt.09.05.2022 had also echoed the above said view and held that the addi�on of 0.5% on the amount guaranteed would be the appropriate benchmark to determine the ALP. Similar decision was also passed by the Bangalore and Pune ITA-TP No. 1860/Hyd/2019 Benches of the Tribunals in the case of GMR Infrastructure Ltd in ITA No.344/Pun/2022 dt.25.05.2022 and Jain Irriga�on Systems in ITA 822/Pun/2022 dt.22.12.2022, respec�vely. Respec�ully following the view taken by the Delhi, Bangalore and Pune Benches of the Tribunals in the above cited cases and also in the case of Vivimed Labs (supra), we partly allow the ground of the assessee and restrict the addi�on to the tune of 0.5% on the amount guaranteed as corporate guarantee commission. 12. Following the above decision of the coordinate Bench, we direct the learned Assessing Officer/learned TPO to adopt the same at 0.50% on the guaranteed amount. Relevant grounds are answered accordingly. 13. Next issue is in respect of the interest on receivables. Again, on this issue also, the assessee had taken a plea before the learned TPO that it is not covered under the defini�on of interna�onal transac�on and it does not require any separate benchmark. Learned Assessing Officer also again relied upon a number of decisions on this aspect and held that the trade receivables are separate interna�onal transac�on requiring separate benchmarking and while following the view taken by the Tribunal in the case of M/s. Logix Microsystems Ltd. Vs. ACIT in I.T.A No.423/Bang/2009, dated 07/10/2010, learned TPO thought it proper to consider the SBI short term deposit rate as appropriate CUP to determine the ALP of the interest on outstanding receivables. 14. Learned CIT(A) upheld the finding of the learned Assessing Officer and observed that post amendment by Finance Act, 2012 introducing explana�on to Sec�on 92B of the Act, if there is any delay in realiza�on of a trade debt arising from the sale of goods or services rendered in the course of carrying on the business, it is liable to be visited with Transfer Pricing adjustment on account of interest income short charged/uncharged. Learned CIT(A) further directed the learned TPO to apply the SBI short term deposit rates for the period beyond the period men�oned in the invoices.
Page 5 of 14
Learned AR argued at length sta�ng that this par�culars transac�on is not covered in the defini�on of interna�onal transac�on as defined under sec�on 92B of the Act; that the receivables are consequen�al/closely linked to the principal transac�on of provision of services; that the re-characterizing the outstanding receivables as unsecured loan extended by the assessee to its AEs is improper; that the assessee is fully funded by its AEs and does not bear any working capital risks; that the assessee does not charge any interest on outstanding receivables from third party customers as well; and that the assessee has outstanding payables due to AEs on which no interest has been levied by the AEs as well. 16. Learned AR, in the alterna�ve, submi�ed that in the case of A�on Chemical India Private Limited vs. ITO in ITA No. 1467/Hyd/2019, by order dated 05/09/2022 a view was taken to the effect that in this sort of cases, the ends of jus�ce would be met by accep�ng the interest rate on similar foreign currency receivables/advances as LIBOR+200 points, and if the Bench comes to the conclusion that the assessee is liable on this aspect, the same view may be adopted in this case also. 17. Per contra, learned DR submi�ed that this aspect does not leave any scope for any discussion in view of the decision of the Hon'ble Delhi High Court in the case of DCIT vs. McKensey knowledge Centre India Pvt. Ltd [2018] 96 taxmann.com 237 (Delhi) and the Co-ordinate Bench of the Delhi Tribunal in the case of Bha�a Airtel services Ltd vs. DCIT, [2021] 126 taxmann.com 315 (Delhi - Trib.) holding that with the introduc�on of the explana�on to sec�on 92B of the Act by Finance Act, 2012 it is a determinable that if there is any delay in the realiza�on of credit arising from the sale of goods or services rendered in the course of carrying on the business, it is liable to be visited with the transfer pricing adjustment on account of interest income short charged/uncharged. Basing on the view taken in a number of decisions of the Tribunal of various Benches, authori�es held that it is incumbent upon the taxpayer to separately benchmark the arm’s length price of the interna�onal transac�on rela�ng to interest on overdue receivables from the AE by way of analysis of func�ons, assets and risks.
Page 6 of 14
Learned DR further argued that the credit period as per the invoice with the AE cannot be contemplated as a comparable in TP regime as it is a controlled transaction and lacks arm’s length characteristic as held by the ITAT in the case of M/s. Technimont ICB P. Ltd., vs. Addl. CIT 138 ITD 23 (Mum); whereas apart from placing reliance on the view taken by the learned DRP for the assessment year 2018-19 which became final, the learned AR also placed reliance on a decision of the Mumbai Bench of the Tribunal in the case of DCIT vs. Indo American jewellery Ltd in ITA No. 5872/mum/2009 for the principle that if an en�ty is engaged in commercial transac�ons with the group en�ty as well as third-party unrelated customers, and if the en�ty is giving credit facility ranging up to 352 days to both group en�ty as well as the third-party unrelated customers, in such case, no addi�on on account of interest adjustment can be made. 19. We have considered the submissions on either side. In the case of the DCIT vs. McKensey knowledge Centre India Pvt. Ltd [2018] 96 taxmann.com 237 (Delhi) Hon'ble Delhi High Court and in the case of Bha�a Airtel services Ltd vs. DCIT, [2021] 126 taxmann.com 315 (Delhi - Trib.) the Co-ordinate Bench of the Delhi Tribunal it was held that with the introduc�on of the explana�on to sec�on 92B of the Act by Finance Act, 2012 it is determinable that if there is any delay in the realiza�on of credit arising from the sale of goods or services rendered in the course of carrying on the business, it is liable to be visited with the transfer pricing adjustment on account of interest income short charged/uncharged. It is, therefore, not open for the assessee to agitate this ques�on as to whether the interest on outstanding receivables is an interna�onal transac�on requiring separate benchmarking �me and again. 20. In respect of the credit period, assessee contended before the learned CIT(A) that instead of considering an ad hoc credit period of 90 days, as adopted by the learned TPO, the credit period as agreed in the invoice should be considered for compu�ng interest on delayed receivables beyond the credit period agreed as per invoice. Assessee relied upon the view taken by the learned DRP in assessee’s own case for the assessment year 2018-19 where the learned DRP directed the learned TPO to consider the credit period agreed as per the invoices. In that year
Page 7 of 14
learned DRP directed the learned TPO to verify the credit period invoice price and to charge the interest for the period beyond such credit period agreed in the invoices. Since the Revenue accepted such findings of the learned DRP and such findings of learned DRP became final, learned CIT(A) in this case followed the same and directed the learned Assessing Officer to verify the invoices and compute the interest considering the credit period as per the invoices instead of 90 days period as adopted by the learned TPO. Learned CIT(A) directed the assessee to furnish the informa�on if required. In the decision of the Mumbai Bench of the Tribunal in the case of DCIT vs. Indo American Jewellery Ltd in ITA No. 5872/mum/2009 it was held that if an en�ty is engaged in commercial transac�ons with the group en�ty as well as third-party unrelated customers, and if the en�ty is giving credit facility ranging up to 352 days to both group en�ty as well as the third-party unrelated customers, in such case, no addi�on on account of interest adjustment can be made. 21. Though the learned DR opposed the prayer of the assessee on this aspect, he could not contradict the fact that in assessee’s own case for the assessment year 2018-19 the learned DRP took a view that the credit period should be considered as per the agreement between the par�es as reflected in the invoices and directed the learned TPO to verify credit period as per invoice and to charge the interest for the period beyond such credit period agreed in the invoices. 22. Apart from this learned AR submi�ed that the assessee extends credit period ranging between 60 days and 240 days for realisa�on of sale proceeds from the non-AEs depending on many factors including terms of payment in respect of a commercial transac�on and the normal business prac�ce and submi�ed that whatever the credit period that is extended by the assessee to the non-AEs may be applied to the case of AEs also because it is the best comparable available in this case. 23. In the circumstances, we are of the considered opinion that when the assessee is extending the credit period between 60 days and 240 days to the non-AEs, and basing on this the learned DRP in the assessment year 2018-19 took a view that the credit period as agreed between the par�es
Page 8 of 14
shall be respected and followed and such a finding of the learned DRP has become final without the Revenue challenging the same, the credit period which is extended to the non-AEs by the assessee shall be extended to the AEs also. On this reasoning we do not find any illegality or irregularity in the findings returned by the learned CIT(A) that the interest shall be record beyond the credit period as agreed between the par�es. 24. Next issue remains to be considered is in respect of the rate of interest. While placing reliance on the decisions reported in Tecnimont ICB House Vs. DCIT [2015] 60 taxmann.com 143 (Mumbai - Trib.), Hon'ble Bombay High Court in PCIT Vs. Tecnimont (P) Ltd., (supra) and CIT Vs. Co�on Naturals (I) (P.) Ltd. [2015] 55 taxmann.com 523 (Delhi), learned AR prayed that LIBOR+200 basis points may be adopted. This aspect is no longer res integra and dealt with by the Mumbai Bench of the Tribunal in the case of Tecnimont ICB House (supra) and confirmed by the Hon'ble Bombay High Court. Co�on Naturals (I) (P.) Ltd. (supra) is also on the same aspect. 25. In the case of the Tecnimont ICB House Vs. DCIT [2015] 60 taxmann.com 143 (Mumbai - Trib.) Tribunal considered the view taken in Everest Kanto Cylinder Ltd. v. Ass�. CIT (LTU) [2014] 52 taxmann.com 395 (Mum.); PMP Auto Components (P.) Ltd. v. [IT Appeal No. 1484 (Mum.) of 2014, dated 22-8-2014]; Hinduja Global Solu�ons Ltd. v. Addl. CIT [2013] 145 ITD 361/35 taxmann.com 348 (Mum.); Tata Autocomp Systems Ltd. v. Ass�. CIT [2012] 52 SOT 48/21 taxmann.com 6 (Mum.); CIT v. Tata Autocomp Systems Ltd. [2015] 56 taxmann.com 206 (Bom.); Four So� Ltd. v. Dy. CIT [2011] 142 TTJ 358 (Hyd.); and Everest Kanto Cylinder Ltd. v. Ass�. CIT (LTU) [2015] 56 taxmann.com 361 (Mum.) and upheld use of LIBOR for the purpose of benchmarking loan/advance given to foreign AE's, and held that the no�onal interest has to be worked out for so called amount receivable from AE, by applying LIBOR interest rate for the purpose of computa�on of transfer pricing adjustment, if any. This view is affirmed by the Hon'ble Bombay High Court in PCIT vs. Tecnimont (P.) Ltd. [2018] 96 taxmann.com 223 (Bombay) observing that in cases where any business enterprise is required to pay interest on delayed payment, it would examine the cost of interest and if the same is
Page 9 of 14
higher than the amount of interest payable on funds obtained locally, it would take a loan from local sources and pay the amounts payable for exports and expenses within �me. Therefore, extending of credit beyond the normal period of sixty days is in substance a gran�ng of loan to an AE so as to enjoy the funds, which the AE would otherwise have to repay within the period of sixty days. On this premise the Hon'ble High Court upheld the view of the Tribunal in compu�ng the interest at LIBOR rates as the rate prevailing in country where the loan is received/consumed by the AE by observing that the same cannot be faulted. 26. In the case of CIT Vs. Co�on Naturals (I) (P.) Ltd. [2015] 55 taxmann.com 523 (Delhi) the Hon'ble Delhi High Court considered the ques�on - whether the interest rate prevailing in India should be applied, for the lender was an Indian company/assessee, or the lending rate prevalent in the United States should be applied, for the borrower was a resident and an assessee of the said country, observed that such a ques�on must be answered by adop�ng and applying a commonsensical and pragma�c reasoning and held that the interest rate should be the market determined interest rate applicable to the currency concerned in which the loan has to be repaid; that the interest rates should not be computed on the basis of interest payable on the currency or legal tender of the place or the country of residence of either party. It is further observed that the interest rates applicable to loans and deposits in the na�onal currency of the borrower or the lender would vary and are dependent upon the fiscal policy of the Central bank, mandate of the Government and several other parameters; that the interest rates payable on currency specific loans/ deposits are significantly universal and globally applicable; that the currency in which the loan is to be re-paid normally determines the rate of return on the money lent, i.e. the rate of interest. While referring to the Klaus Vogel on Double Taxa�on Conven�ons (Third Edi�on) under Ar�cle 11 in paragraph 115, the Hon'ble High Court held that the PLR rate, therefore, would not be applicable and should not be applied for determining the interest rate and the PLR rates are not applicable to loans to be re-paid in foreign currency. Hon'ble Court accordingly held that whatever the principle that is applicable to the case of outbound loans, would be equally applicable to inbound loans given to Indian subsidiaries Page 10 of 14
of foreign AEs, that the parameters cannot be different for outbound and inbound loans, and a similar reasoning applies to both inbound and outbound loans. 27. In the case of PCIT vs. Tecnimont (P.) Ltd. [2018] 96 taxmann.com 223 (Bombay) AY. 2009-10, Hon’ble Bombay High Court held that interest chargeable on delayed recovery of export receivables from AEs should be taken at LIBOR rates for determining ALP of no�onal interest on delayed recovery. 28. Respec�ully following the judicial opinion stated supra, we are of the considered opinion that the ends of jus�ce would be met by accep�ng the interest rate on similar foreign currency receivables/advances as LIBOR+200 points. We direct the learned Assessing Officer / learned TPO to adopt the same. Grounds are partly allowed accordingly. 29. Next and last issue relates to the weighted deduc�on claimed by the assessee in respect of the expenditure incurred on the expenditure not quan�fied in the expenditure approved by the DSIR reflected in part B of form 3CL, and on clinical trials. There is no dispute that the expenditure that is not quan�fied in the approval by the DSIR, such an expenditure was incurred towards rates and taxes, travelling expenses of research units. Both the authori�es held that for claiming weighted deduc�on, such an expenditure must have been approved by the prescribed authority and that no excep�ons to this rule are provided in the Act. Though such an expenditure was incurred in rela�on to the scien�fic research and development, the requirement of approval by the prescribed authority is not fulfilled in this case and therefore, it is not qualified for weighted deduc�on, but at the same �me since there is no dispute as to the incurring of such expenditure by the assessee, the said expenditure is qualified for hundred percent deduc�on. To the extent we approve the view taken in the impugned order. 30. Coming to the expenditure on clinical trials this issue is no longer res integra and in fact been dealt with by the Hon’ble Gujarat High Court in extenso in the case of CIT vs. Cadila healthcare Ltd (2013) taxmann.com 300 (Gujarat), and the Hon’ble court held that the clinical trials may not
Page 11 of 14
always be possible to be conducted in the closed laboratory or in house like facili�es and are required to be conducted outside the approved authority and, therefore, the restric�ve meaning suggested by the Revenue to the expenses men�oned in the explana�on to the sec�on such as a clinical drug trials and obtaining approvals from the regulatory authori�es, which normally happens outside the approved R&D facility, make the explana�on meaningless. 31. Learned DR submi�ed that this decision of the Hon’ble Gujarat High Court has not a�ained the finality because the Hon’ble Apex Court remanded the case to the file of the Hon’ble Gujarat High Court and therefore, the ma�er was sub judice before the Hon’ble High Court and that is the reason why the lower authori�es are not following the decision rendered by the Tribunal in the earlier assessment years. 32. In reply, learned AR submi�ed that as could be seen from the order of the Hon’ble Supreme Court in special leave pe��on to appeal (C) No. 770/2015, dated 13/10/2015 the grievance of the Revenue was with reference to non-framing of certain ques�ons, it was considered by the Hon’ble Apex Court and held that such ques�ons were substan�al ques�ons of law, and thereupon referred the ma�er to the Hon’ble Gujarat High Court to hear the appeal on the aforesaid three ques�ons of law, but the judgement already passed by the Hon’ble Gujarat High Court touching the aspect of allowability of weighted deduc�on has not been set aside. He placed reliance on the decision taken by a coordinate Bench in assessee’s own case for the assessment year 2013-14 and 2014-15 in ITA numbers 1772 and 1773 /Hyd/ 2017 where the Tribunal on a perusal of the decision of the Hon’ble Apex Court clarified that what was decided in the Cadilla (supra) by the Hon'ble Gujarat High Court was not in fact disturbed by the Hon'ble Apex Court, but remanded the ma�er only in respect of certain substan�al ques�ons. 33. On a careful perusal of the record we find that the Hon’ble Gujarat High Court rendered the decision in Cadila Healthcare Ltd (supra) holding that the clinical trials are not always possible to be conducted in the closed laboratory or in house like facili�es and are required to be conducted
Page 12 of 14
outside the approved facility and if we go by the restricted interpreta�on resorted to by the Revenue, such an interpreta�on renders the explana�on meaningless where the expenses for obtaining approvals from the regulatory authori�es are also included in the clinical trials, because such expenses for obtaining approvals from the regulatory authori�es normally happen outside the approved R&D facility. Subsequent to the SLP preferred by the Department and three issues were remanded for considera�on by the Hon’ble Gujarat High Court by order dated 13/10/2015, the Hon’ble Gujarat High Court, by order dated 25/2/2020 in PCIT vs. M/s Sun pharmaceu�cals industries Ltd in R/Tax Appeal No. 92 of 2020, observed that in view of the decision in Cadila healthcare Ltd (supra) the issue rela�ng to the allowability of weighted deduc�on under sec�on 35(2AB) of the Act in respect of clinical trials expenses incurred outside the approved facility stood covered and on that ground did not admit such an issue for considera�on. 34. From the above it is clear that the issue has clearly been covered by the decision of the Hon’ble Gujarat Court High Court in the case of Cadila healthcare Ltd (supra), referred to and followed in the case of M/s Sun Pharmaceu�cals Industries Limited (supra). A coordinate Bench of this Tribunal in assessee’s own case for the assessment year 2018-19 having no�ced the judicial review on this aspect, including the argument advanced in that case, and basing on CIT vs. Vegetable Products Ltd 88 ITR 192 (SC) reached a conclusion that when once the clinical trial expenses incurred outside the approved R&D facili�es, were approved by the prescribed authority the assessee is en�tled to claim deduc�on under sec�on 35(2AB) of the Act. Respec�ully following the same we hold the issue in favour of the assessee and allow weighted deduc�on in respect of the expenses incurred on clinical trials.
Page 13 of 14
In the result, appeal of the Revenue is dismissed and the appeal of the assessee is allowed in part. Order pronounced in the open court on this the 23rd day of July, 2024. Sd/- Sd/- (MADHUSUDAN SAWDIA) (K. NARASIMHA CHARY) ACCOUNTANT MEMBER JUDICIAL MEMBER Hyderabad, Dated: 23/07/2024 Copy forwarded to: 1. ACIT, Central Circle 1(2) 7th Floor, Aayakar Bhavan, Basheerbagh, Hyderabad. 2. Aurobindo Pharma Ltd, Plot 2, Mythri Vihar, Behind Mythri Vanam, Ameerpet, Hyderabad 500038 3. The Pr.CIT, Central, Hyderabad 4. CIT(IT & TP) Hyderabad 5. DR, ITAT, Hyderabad. 6. GUARD FILE TRUE COPY
ASSISTANT REGISTRAR ITAT, HYDERABAD
Page 14 of 14
